Calithera Biosciences, Inc.
Compositions and methods for inhibiting arginase activity
Last updated:
Abstract:
The disclosure relates to a novel class of compounds that exhibit activity inhibitory activity toward arginase, and pharmaceutical compositions comprising the compounds of the disclosure. Also provided herein are methods of treating cancer with the arginase inhibitors of the disclosure.
Status:
Grant
Type:
Utility
Filling date:
29 Mar 2019
Issue date:
24 Mar 2020